PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
MDWD MediWound
- 18.760
- +0.140+0.75%
Close Feb 14 16:00 ET
- 18.760
- 0.0000.00%
Post 16:01 ET
202.42MMarket Cap-6.45P/E (TTM)
19.200High18.310Low48.87KVolume18.670Open18.620Pre Close922.24KTurnover0.65%Turnover RatioLossP/E (Static)10.79MShares24.00052wk High5.91P/B140.08MFloat Cap12.78052wk Low--Dividend TTM7.47MShs Float135.170Historical High--Div YieldTTM4.78%Amplitude7.100Historical Low18.871Avg Price1Lot Size
About MediWound Company
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.
Company Profile
SymbolMDWD
Company NameMediWound
Listing DateMar 20, 2014
Issue Price14.00
Founded2000
CEOMr. Ofer Gonen
MarketNASDAQ
Employees100
Fiscal Year Ends12-31
Address42 Hayarkon Street
CityYavne
ProvinceHaMerkaz
CountryIsrael
Zip Code8122745
Phone972-77-971-4100
Websitehttp://www.mediwound.com
Company Executives
- Name
- Position
- Salary
- Ofer Gonen
- Director and Chief Executive Officer
- 1.13M
- Hani Luxenburg
- Chief Financial Officer
- 244.00K
- Dr. Robert Snyder, M. Sc.
- Chief Medical Officer
- --
- Ety Klinger
- Chief Research and Development Officer
- 479.00K
- Shmulik Hess
- Chief Operating Officer and Chief Commercial Officer
- --
- Yaron Meyer
- Executive Vice President, General Counsel and Corporate Secretary
- 379.00K
- Nachum Shamir
- Chairman of the Board
- --
- Stefan T. Wills
- Director
- --
- David Fox
- Independent Director
- --
- Stephen T. Willis
- Independent Director
- --
- Shmuel Rubinstein
- Independent Director
- --
- Dr. Vickie R. Driver
- Independent Director
- --
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!